Kevin Michael Mullins has sold LFST and made no open-market buys since Apr 2022

Chief Development Officer at LifeStance Health Group, Inc.

SEC CIK 0001864233 · Filings on SEC.gov ↗

$0Bought

$11.2MSold

NoneLast buy

Every filing

18 filings since Apr 2022, newest first

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$471K−2.0%Jun 13

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$57KApr 19

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$282K−1.0%Mar 18

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$923K−2.0%Mar 4

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$741K−2.0%Dec 4

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$198K−1.0%Nov 8

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$496K−2.0%Nov 6

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$749K−2.0%Oct 3

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$1.2M−3.0%Jul 7

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$1.8M−4.0%Jul 6

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$594K−1.0%Jun 27

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$531K−1.0%Apr 6

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$723K−2.0%Apr 4

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$270K−1.0%Mar 17

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$748K−2.0%Mar 10

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$580K−1.0%Oct 3

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$418K−1.0%Jun 14

LFSTSell

Lifestance Health Group, Inc.

Chief Development Officer

$494K−1.0%Apr 22

Filings come from SEC EDGAR. Not investment advice.